1. Home
  2. BJDX vs VTAK Comparison

BJDX vs VTAK Comparison

Compare BJDX & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJDX
  • VTAK
  • Stock Information
  • Founded
  • BJDX 2015
  • VTAK 2002
  • Country
  • BJDX United States
  • VTAK United States
  • Employees
  • BJDX N/A
  • VTAK N/A
  • Industry
  • BJDX Medical Specialities
  • VTAK Medical/Dental Instruments
  • Sector
  • BJDX Health Care
  • VTAK Health Care
  • Exchange
  • BJDX Nasdaq
  • VTAK Nasdaq
  • Market Cap
  • BJDX 3.9M
  • VTAK 4.1M
  • IPO Year
  • BJDX 2021
  • VTAK 2018
  • Fundamental
  • Price
  • BJDX $1.70
  • VTAK $2.25
  • Analyst Decision
  • BJDX
  • VTAK
  • Analyst Count
  • BJDX 0
  • VTAK 0
  • Target Price
  • BJDX N/A
  • VTAK N/A
  • AVG Volume (30 Days)
  • BJDX 103.5K
  • VTAK 35.3K
  • Earning Date
  • BJDX 11-07-2025
  • VTAK 11-14-2025
  • Dividend Yield
  • BJDX N/A
  • VTAK N/A
  • EPS Growth
  • BJDX N/A
  • VTAK N/A
  • EPS
  • BJDX N/A
  • VTAK N/A
  • Revenue
  • BJDX N/A
  • VTAK $600,000.00
  • Revenue This Year
  • BJDX N/A
  • VTAK $822.86
  • Revenue Next Year
  • BJDX $55.56
  • VTAK $168.42
  • P/E Ratio
  • BJDX N/A
  • VTAK N/A
  • Revenue Growth
  • BJDX N/A
  • VTAK 37.62
  • 52 Week Low
  • BJDX $1.26
  • VTAK $2.13
  • 52 Week High
  • BJDX $10.20
  • VTAK $15.68
  • Technical
  • Relative Strength Index (RSI)
  • BJDX 41.64
  • VTAK 43.50
  • Support Level
  • BJDX $1.39
  • VTAK $2.13
  • Resistance Level
  • BJDX $2.34
  • VTAK $2.56
  • Average True Range (ATR)
  • BJDX 0.17
  • VTAK 0.12
  • MACD
  • BJDX -0.10
  • VTAK -0.04
  • Stochastic Oscillator
  • BJDX 28.16
  • VTAK 30.83

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: